QSC Tirzepatide is a high-purity peptide compound developed for research applications. This white powder formulation demonstrates dual agonist activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, making it particularly valuable for metabolic disorder studies.
The compound shows superior efficacy in glucose control compared to selective GLP-1 receptor agonists, with research indicating significant potential in type 2 diabetes investigations. QSC Tirzepatide's molecular structure (C225H348N48O68) and weight (4813.527g/mol) have been precisely characterized for research accuracy.
For laboratory use, QSC Tirzepatide is supplied in lyophilized powder form with vacuum-sealed vials to ensure stability. Researchers should store the compound in cool, dry conditions (2-8°C) protected from light exposure. Long-term storage at -20°C is recommended for optimal preservation.
This product is intended for research purposes only and is not for human consumption. Proper laboratory handling procedures should always be followed when working with QSC Tirzepatide.